Clinical Trial Update: Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer

View source ↗

Summary

This clinical trial update notes completion of a study evaluating the development of the Peritoneal Carcinomatosis Index (PCI) in ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Ovarian Cancer | Status: COMPLETED